Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Chronic obstructive pulmonary disease and comorbidities
M Decramer, W Janssens - The Lancet Respiratory Medicine, 2013 - thelancet.com
Results of epidemiological studies have shown that chronic obstructive pulmonary disease
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease
BR Celli, M Decramer, JA Wedzicha… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …
Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer
PT King - Clinical and translational medicine, 2015 - Springer
Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation that
persists after smoking cessation. This inflammation is heterogeneous but the key …
persists after smoking cessation. This inflammation is heterogeneous but the key …
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
JA Wedzicha, SE Brill, JP Allinson, GC Donaldson - BMC medicine, 2013 - Springer
Exacerbations of chronic obstructive pulmonary disease (COPD) are important events that
carry significant consequences for patients. Some patients experience frequent …
carry significant consequences for patients. Some patients experience frequent …
Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications
H Qureshi, A Sharafkhaneh… - … advances in chronic …, 2014 - journals.sagepub.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide and results in an economic and social burden that is both substantial and …
worldwide and results in an economic and social burden that is both substantial and …
Time‐related biases in pharmacoepidemiology
S Suissa, S Dell'Aniello - Pharmacoepidemiology and drug …, 2020 - Wiley Online Library
Purpose Observational studies using computerized healthcare databases have become
popular to investigate the potential effectiveness of old drugs for new indications. Many of …
popular to investigate the potential effectiveness of old drugs for new indications. Many of …
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
The cholesterol biosynthesis pathway, also known as the mevalonate (MVA) pathway, is an
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …
Comorbidities and systemic effects of chronic obstructive pulmonary disease
G Choudhury, R Rabinovich… - Clinics in chest …, 2014 - chestmed.theclinics.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It has been projected to move from the sixth to the third most common cause of …
worldwide. It has been projected to move from the sixth to the third most common cause of …
Pharmacological actions of statins: potential utility in COPD
RP Young, R Hopkins, TE Eaton - European Respiratory …, 2009 - publications.ersnet.org
Chronic obstructive pulmonary disease (COPD) is characterised by minimally reversible
airflow limitation and features of systemic inflammation. Current therapies for COPD have …
airflow limitation and features of systemic inflammation. Current therapies for COPD have …
Statins, systemic inflammation and risk of death in COPD: the Rotterdam study
L Lahousse, DW Loth, GF Joos, A Hofman… - Pulmonary …, 2013 - Elsevier
BACKGROUND: Studies suggest that statins decrease mortality in COPD patients but it is
unknown which patients might benefit most. OBJECTIVES: We investigated whether statins …
unknown which patients might benefit most. OBJECTIVES: We investigated whether statins …